Disclosure: PeptideOnline earns commissions from some links on this page, at no extra cost to you. See our affiliate disclosure.
The short answer
You can report a side effect from a peptide directly to FDA through MedWatch, its safety reporting program. Consumers can file online with the MedWatch Online Reporting Form, use the consumer-friendly Form FDA 3500B, or call 1-888-INFO-FDA (1-888-463-6332) and press 2 for help. Include the exact product name, who sold or dispensed it, the lot number, the dates, what happened, and the outcome. Keep the vial, packaging and any certificate of analysis.
Get care first. If a reaction is severe, such as trouble breathing, swelling of the face or throat, chest pain, fainting, severe abdominal pain or signs of a spreading infection, call 911 or go to an emergency department. Reporting can wait until you're safe.
- Anyone can report to MedWatch; FDA says you may complete the online form yourself.
- Your health care provider is not required to report to FDA, so don't assume someone else has.
- Keep the vial, box, label photos, COA and order records; the lot number is the most valuable detail.
- FDA counted 990 reports for compounded semaglutide and more than 730 for compounded tirzepatide as of May 31, 2026, and says these are likely underreported.
Why reporting matters
FDA's safety monitoring relies heavily on voluntary reports. For approved drugs, manufacturers have reporting obligations. For compounded drugs and research-labeled products, much of the signal depends on patients and clinicians who choose to report.
Those reports add up. FDA's page on unapproved GLP-1 drugs, current as of October 1, 2026, reports that as of May 31, 2026 the agency had received 990 adverse event reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide. FDA notes these numbers are likely underreported, and its analysis of the reports identified dosing errors as a recurring problem, including patients measuring incorrect doses themselves. That kind of pattern only becomes visible when individual people report.
Our side effects and safety guide covers what is known about common peptide reactions.
Step by step: filing a MedWatch report
- Choose your route. The MedWatch Online Reporting Form is the most direct. You can also download Form FDA 3500B, the consumer version (a Spanish version is available), or use Form FDA 3500, which is designed for health professionals but which FDA says consumers may also use. If you need help, call 1-888-INFO-FDA (1-888-463-6332) and press 2.
- Describe the product precisely. Use the name exactly as it appears on the label, including strength and form. Say whether it was FDA-approved, compounded by a pharmacy, or sold as a research chemical.
- Name the source. The pharmacy name and address for a prescription, or the seller's name and website for a research product.
- Give the lot number and dates. Lot, expiration or beyond-use date if any, when you started, and when the reaction began.
- Describe what happened. Symptoms, timing, how long they lasted, what treatment you received, and the outcome (recovered, ongoing, hospitalized).
- List everything else you take. Prescription drugs, other peptides, supplements. Interactions are part of the picture; see peptide-drug interactions.
- Submit and keep a copy. Save the confirmation and a copy of what you sent.
FDA also encourages patients to take the reporting form to their doctor. That can help with medical details, but you don't need a doctor's involvement to report.
What to keep, and why
| Keep | Why |
|---|---|
| The vial (even if empty) and any remaining product | May be needed if FDA, the pharmacy or the seller investigates |
| Box, label and packaging, plus photos | Shows lot number, seller, storage claims and condition |
| Certificate of analysis | Shows what the seller claims was tested; check whether the lot matches |
| Prescription label and pharmacy receipt | Identifies the dispensing pharmacy and prescriber |
| Order confirmation, invoices, chat messages | Identifies a research seller, especially if its site disappears |
| Medical records from any visit | Documents diagnosis and treatment |
Store the vial safely and out of reach of children. Don't keep using a product you suspect caused a reaction. Our label decoder shows where to find lot numbers on different kinds of labels.
Compounded and research-labeled products
FDA's MedWatch page lists the kinds of products it covers, including drugs, biologics, devices and dietary supplements. It doesn't single out compounded or research-labeled products, but FDA's own counts of reports for compounded GLP-1s show those reports are received and analyzed.
For a research-labeled product, report what you know: the name on the label, the seller, the lot, and the website. If the product was sold in a way that suggests it was marketed for people, FDA's BeSafeRx program also links to a way to report websites you believe are illegally selling medicine.
For a compounded prescription, also tell the dispensing pharmacy and your prescriber. If you believe the pharmacy itself has a problem, you can contact the state board of pharmacy where it is licensed; our guide to verifying a compounding pharmacy shows how to find it.
Writing a useful description
The narrative box is where most reports become useful or useless. Investigators read many of these; a clear, specific timeline helps more than adjectives. A simple structure:
- Product and source: "[Product name and strength as labeled], [compounded / research-labeled / brand], from [pharmacy or seller], lot [number]."
- Use: when you started, how it was prescribed or obtained, and any recent change.
- Event: what you noticed first, when, and how it progressed.
- Care: where you were seen, tests done, diagnosis given, treatment.
- Outcome: resolved, improving, ongoing, or required hospitalization, and whether symptoms stopped after you stopped the product.
- Anything unusual about the product: appearance, packaging, temperature on arrival, a COA that didn't match the lot.
Stick to what you observed and what clinicians told you. You don't need to prove the product caused the problem; that is FDA's job when it looks across many reports.
What happens after you report
Reports go into FDA's adverse event databases, where safety staff look for patterns across reports rather than investigating each one individually. You may not hear back. FDA may contact you if it needs more detail, which is one reason to include accurate contact information. A single report is not proof that a product caused harm, and a lack of reports is not proof of safety; the system works by accumulation.
If you report on behalf of someone else, such as a family member, include your relationship and their consent where possible, and the same product and lot details.
Product problems, not just side effects
MedWatch isn't only for reactions. You can also use it to report a problem with the product itself, even if nobody was harmed: a vial that arrived cracked or with a broken seal, particles in a solution, a label that doesn't match the contents, a lot number that doesn't appear on any COA, or packaging that suggests a counterfeit. Those reports help FDA spot quality issues before they cause harm.
For a product-quality report, the same details matter: exact product name, source, lot number, and photos. Describe what you observed, not what you suspect it means. Keep the product until you know whether anyone will want to examine it.
Other reports worth making
- The seller or pharmacy. Report the reaction in writing with the lot number. Ask whether other reports have been received for the same lot.
- Your prescriber. Even if you used a research product on your own, your clinician should know what happened.
- Your procedure team, if you have surgery or endoscopy coming up and the reaction involved a GLP-1. Our summary of GLP-1 anesthesia guidance explains why GI symptoms matter before procedures.
- Poison control, at 1-800-222-1222, if you think you took too much or took the wrong product.
If you suspect the product was counterfeit or contaminated, our contamination and counterfeiting guide covers the signs and what else to document.
Frequently asked questions
Can I report a peptide side effect to FDA myself?
Yes. FDA says consumers may complete the MedWatch Online Reporting Form themselves. You can also use the consumer Form FDA 3500B or call 1-888-INFO-FDA and press 2.
Will my doctor report my side effect to FDA?
Not necessarily. FDA notes that health care providers are not required to report to FDA, so if you want the event on record, file the report yourself or ask your provider to help.
Can I report a side effect from a research peptide or compounded drug?
Yes. Report the product name exactly as labeled, the seller or pharmacy, and the lot number. FDA tracks reports for compounded drugs; for example, it reported 990 reports for compounded semaglutide as of May 31, 2026.
What information do I need for a MedWatch report?
The product name and strength as labeled, who sold or dispensed it, the lot number, the dates you used it and when symptoms began, what happened, the outcome, and other medicines or supplements you take.
Should I throw away a peptide that caused a reaction?
Keep it, along with the packaging, label and any certificate of analysis, stored safely away from children. Stop using it, and keep it until any investigation or complaint is resolved.
Sources and primary references
- FDA MedWatch: Reporting Serious Problems to FDA (online form, Form 3500B, phone)
- FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (adverse event counts as of May 31, 2026)
- FDA: BeSafeRx (reporting suspected illegal online medicine sales)
Regulatory status can change. PeptideOnline date-stamps regulatory summaries and links to primary agency sources so readers can verify the current position.
Medical disclaimer: This article is for educational and research-information purposes only. It does not provide diagnosis, prescribing, dosing, injection, or individualized treatment advice. It has not been reviewed by a clinician. FDA-approved drugs, compounded prescription products, and research-use chemicals are different product categories and should not be treated as interchangeable. See our medical disclaimer and editorial policy.